Use of a VEGF antagonist in combination with radiation therapy

Details for Australian Patent Application No. 2004264891 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Yancopoulos, George; Wachsberger, Phyllis R.; Dicker, Adam P.; Burd, Randy; Holash, Jocelyn

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004264891

PCT Pub. Number WO2005/016369

Priority 60/492,864 06.08.03 US

Filing date 30 July 2004

Wipo publication date 24 February 2005

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 February 2006 PCT application entered the National Phase

  PCT publication WO2005/016369 Priority application(s): WO2005/016369

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264898-Compositions and methods relating to freezer-to-oven doughs

2004264886-Methods for administering aripiprazole